[ NOTE_03 ]
Investor Note
May 2026
What this biotech paper actually means for investors
A worked example of separating the headline finding from the underlying technical risk in a recent translational study.
Forthcoming
Insights
Short notes translating science for business audiences.
Clear, concise, and non-academic. Written by working scientists for investors and operators who need signal without jargon.
[ NOTE_02 ]
Primer
April 2026
Explaining metabolomics in precision medicine
A short primer on what metabolomics measures, where the assay confidence breaks down, and which claims to scrutinize in a pitch.
Forthcoming
[ NOTE_01 ]
Landscape
March 2026
Neuroscience trends shaping aging research
An overview of which aging-adjacent neuroscience areas have moved from speculation toward investable hypotheses.
Forthcoming
New notes are published periodically. For private analysis on a specific paper, asset, or technology area, engage the collective directly.